| Opinion Published In: May, 2016 | |
| FOLFOX4 as First Line Treatment in Advanced Hepatocellular Cancer, when Sorafenib is not Available: Can it be an Option? | |
| Piyush Vyas1*, Marta Dudek1, Ewa Zurawinska Grzelka1, Mateusz Cieslak1, Anna Dryja1 and Seema Vyas2 | |
| Case Report Published In: June, 2016 | |
| Blood-Drop Liquid Biopsy for Monitoring Mutation Load and Therapeutic Responses | |
| Nader Javadi1, Andrew Ford2 and Chen-Hsiung Yeh2 | |
| Review Article Published In: June, 2016 | |
| The Psychological Aspects of the Treatments Involved in Cancer Quackery: Historical Review | |
| Wilson Onuigbo* | |
| Research Article Published In: August, 2016 | |
| Role of Distal loopogram Before Defunctioning Stoma Reversal- Results From An Indian Tertiary-Care Center | |
| *Girish K Kundagulwar1, Vishwas D Pai1, Supreeta Arya2, Prachi Patil3 and Avanish P Saklani1 | |
| Editorial Published In: August, 2016 | |
| Chimeric Antigen Receptor Engineered T (CAR-T) Cells and Cancer Therapy | |
| *Nahla A M Hamed | |
Open Access by Juniper Publishers is licensed under a Creative Commons Attribution 4.0 International License. Based on a work at www.juniperpublishers.com. 
| Above IE 7.0 version | Privacy Policy
CTOIJ Home
